Open Label, Adaptive, Parallel Group PET Study Using RO7017773 And [11C] RO15-4513

Summary

This is a single dose (SD), non-randomized, open-label, adaptive, parallel group study with the purpose of investigating the occupancy of alpha5-containing GABAA receptors by RO7017773 in healthy participants.

Timeline

Start

2018-04-24

Primary completion

2018-06-22

Completion

2018-06-22

Drugs

Indications